Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

in Philadelphia-Chromosome-Negative Acute Lymphoblastic Leukemia, Late Relapses Are Not Uncommon, Occur Mostly in Patients at Standard Risk and Have a Relatively Favorable Outcome. Results of the International ALL Trial: MRC Ukallxii/ECOG E2993

Chezi Ganzel, Wang Xin Victoria, Adele K. Fielding, MB, BS, PhD, Jacob M. Rowe, MD, Susan M Richards, PhD, Georgina Buck, Rajesh Chopra, PhD, I. Jill Durrant, David Marks, MD PhD, Ian M. Franklin, MD, Andrew K McMilan, Mark R Litzow, MD, Elisabeth Paietta, PhD, Selina Luger, MD, Peter H Wiernik, Dan Douer, MD, Hillard M. Lazarus, MD, Martin S Tallman, MD, Anthony H. Goldstone, FRCP, FRCPath

Blood (2015) 126 (23): 795.

https://doi.org/10.1182/blood.V126.23.795.795

Published: 2015

Journal Articles

Long-Term Follow-up of HCV Infected Stem Cell Transplant Patients and Effects of Antiviral Therapy.

Per T. Ljungman, MD, PhD, Anna Locasciulli, MD, V. Gomez-Garcia de Soria, MD, Albert N. Bekassy, MD, MSc, Lorentz J. Brinch, MD, PhD, Ildefonso Espigado, MD, Augustin Ferrant, MD, PhD, Ian M. Franklin, MD, Joan O'Riordan, MB, MRCP, FRCPath, Montserrat Rovira, MD, PhD, Peter J. Shaw, MBBS, FRACP, MA, MRCP, Hermann Einsele, MD

Blood (2009) 114 (22): 1141.

https://doi.org/10.1182/blood.V114.22.1141.1141

Published: 2009

Journal Articles

Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993

Adele K. Fielding, Jacob M. Rowe, Susan M. Richards, Georgina Buck, Anthony V. Moorman, I. Jill Durrant, David I. Marks, Andrew K. McMillan, Mark R. Litzow, Hillard M. Lazarus, Letizia Foroni, Gordon Dewald, Ian M. Franklin, Selina M. Luger, Elisabeth Paietta, Peter H. Wiernik, Martin S. Tallman, Anthony H. Goldstone

Blood (2009) 113 (19): 4489–4496.

https://doi.org/10.1182/blood-2009-01-199380

Published: 2009

Journal Articles

Standard Consolidation/Maintenance Chemotherapy Is Consistently Superior to a Single Autologous Transplant for Adult Patients with Acute Lymphoblastic Leukemia: Results of the International ALL Trial (MRC UKALL XII/ECOG E2993)

Jacob M. Rowe, MD, Georgina Buck, Anthony V Moorman, MD, Martin S Tallman, MD, Susan M Richards, Ph.D, Adele K Fielding, MD, Ph.D, Alan K. Burnett, MD, FRCP, Ian M Franklin, MD, Peter H. Wiernik, MD, Hillard M Lazarus, MD, Elisabeth Paietta, PhD, Mark R. Litzow, MD, David I Marks, MD, Selina Luger, MD, Gordon W. Dewald, PhD, PhD, FACMG, Anthony H. Goldstone, FRCP, FRCPath

Blood (2008) 112 (11): 3314.

https://doi.org/10.1182/blood.V112.11.3314.3314

Published: 2008

Journal Articles

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)

Anthony H. Goldstone, Susan M. Richards, Hillard M. Lazarus, Martin S. Tallman, Georgina Buck, Adele K. Fielding, Alan K. Burnett, Raj Chopra, Peter H. Wiernik, Letizia Foroni, Elisabeth Paietta, Mark R. Litzow, David I. Marks, Jill Durrant, Andrew McMillan, Ian M. Franklin, Selina Luger, Niculae Ciobanu, Jacob M. Rowe

Blood (2008) 111 (4): 1827–1833.

https://doi.org/10.1182/blood-2007-10-116582

Published: 2008

Includes: Supplemental data

Journal Articles

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study

Adele K. Fielding, Susan M. Richards, Rajesh Chopra, Hillard M. Lazarus, Mark R. Litzow, Georgina Buck, I. Jill Durrant, Selina M. Luger, David I. Marks, Ian M. Franklin, Andrew K. McMillan, Martin S. Tallman, Jacob M. Rowe, Anthony H. Goldstone, Medical Research Council of the United Kingdom Adult ALL Working Party and the Eastern Cooperative Oncology Group

Blood (2006) 109 (3): 944–950.

https://doi.org/10.1182/blood-2006-05-018192

Published: 2006

Journal Articles

Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993

Hillard M. Lazarus, Susan M. Richards, Raj Chopra, Mark R. Litzow, Alan K. Burnett, Peter H. Wiernik, Ian M. Franklin, Martin S. Tallman, Lucy Cook, Georgina Buck, I. Jill Durrant, Jacob M. Rowe, Anthony H. Goldstone, for the Medical Research Council (MRC)/National Cancer Research Institute (NCRI) Adult Leukaemia Working Party of the United Kingdom and the Eastern Cooperative Oncology Group

Blood (2006) 108 (2): 465–472.

https://doi.org/10.1182/blood-2005-11-4666

Published: 2006

Journal Articles

Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993

Jacob M. Rowe, Georgina Buck, Alan K. Burnett, Raj Chopra, Peter H. Wiernik, Susan M. Richards, Hillard M. Lazarus, Ian M. Franklin, Mark R. Litzow, Niculae Ciobanu, H. Grant Prentice, Jill Durrant, Martin S. Tallman, Anthony H. Goldstone, for ECOG and the MRC/NCRI Adult Leukemia Working Party

Blood (2005) 106 (12): 3760–3767.

https://doi.org/10.1182/blood-2005-04-1623

Published: 2005

Journal Articles

Adult Patients with Acute Lymphoblastic Leukemia (ALL) and Central Nervous System (CNS) Leukemia at Diagnosis May Attain Durable Complete Remissions (CR). Results from the International ALL Trial (MRC UKALL-XII/ECOG E2993).

Hillard M. Lazarus, MD, Sue M. Richards, Raj Chopra, MD, Mark R. Litzow, MD, Alan K. Burnett, MD, Peter H. Wiernik, MD, Ian M. Franklin, MD, Martin S. Tallman, MD, G. Buck, Jill Durrant, Jacob M. Rowe, MD, Anthony H. Goldstone, MD

Blood (2004) 104 (11): 4484.

https://doi.org/10.1182/blood.V104.11.4484.4484

Published: 2004

Journal Articles

The Outcome of 551 1 st CR Transplants in Adult ALL from the UKALL XII/ECOG 2993 Study.

Anthony H. Goldstone, Hillard J. Lazarus, Sue M. Richards, Mark R. Litzow, Raj Chopra, Alan Burnett, Peter H. Wiernik, Ian M. Franklin, H. G. Prentice, Martin Tallman, G. Harrison, Jill Durrant, Jacob Rowe

Blood (2004) 104 (11): 615.

https://doi.org/10.1182/blood.V104.11.615.615

Published: 2004

NARROW

in Philadelphia-Chromosome-Negative Acute Lymphoblastic Leukemia, Late Relapses Are Not Uncommon, Occur Mostly in Patients at Standard Risk and Have a Relatively Favorable Outcome. Results of the International ALL Trial: MRC Ukallxii/ECOG E2993

Long-Term Follow-up of HCV Infected Stem Cell Transplant Patients and Effects of Antiviral Therapy.

Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993

Standard Consolidation/Maintenance Chemotherapy Is Consistently Superior to a Single Autologous Transplant for Adult Patients with Acute Lymphoblastic Leukemia: Results of the International ALL Trial (MRC UKALL XII/ECOG E2993)

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study

Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993

Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993

Adult Patients with Acute Lymphoblastic Leukemia (ALL) and Central Nervous System (CNS) Leukemia at Diagnosis May Attain Durable Complete Remissions (CR). Results from the International ALL Trial (MRC UKALL-XII/ECOG E2993).

The Outcome of 551 1 st CR Transplants in Adult ALL from the UKALL XII/ECOG 2993 Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only